BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16900107)

  • 1. Lost in validation.
    Nat Biotechnol; 2006 Aug; 24(8):869. PubMed ID: 16900107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of cutaneous T-cell lymphoma].
    Assaf C; Weichenthal M
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):256-8. PubMed ID: 18315629
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton treatment of uveal melanomas.
    Bornfeld N
    Strahlenther Onkol; 2007 Jan; 183(1):1-2. PubMed ID: 17225938
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical standards and clinical practice.
    Hickie I; Hickie C
    Aust N Z J Psychiatry; 1993 Mar; 27(1):157. PubMed ID: 8481156
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereotactic body radiation therapy: a new paradigm in radiotherapy management of cancer.
    Solberg TD; Kavanagh BD; Medin PM
    J Am Coll Radiol; 2008 May; 5(5):673-7. PubMed ID: 18442775
    [No Abstract]   [Full Text] [Related]  

  • 6. [Panorama of dermatologic practice].
    Hautarzt; 2008 Jan; 59(1):5-9. PubMed ID: 18217172
    [No Abstract]   [Full Text] [Related]  

  • 7. Contact dermatitis.
    Brasch J; Becker D; Aberer W; Bircher A; Kränke B; Denzer-Fürst S; Schnuch A
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):943-51. PubMed ID: 17910679
    [No Abstract]   [Full Text] [Related]  

  • 8. Remarks concerning new tools and methodologies for research and clinical practice.
    Kingston R
    Thromb Res; 2005; 117(1-2):119-21; discussion 145-51. PubMed ID: 16139871
    [No Abstract]   [Full Text] [Related]  

  • 9. [New therapeutic options for head and neck squamous cell carcinomas].
    Dietz A
    HNO; 2008 Jun; 56(6):572. PubMed ID: 18483715
    [No Abstract]   [Full Text] [Related]  

  • 10. [Developments in diagnosis and treatment of schizophrenic psychoses].
    Maier W; Falkai P
    Nervenarzt; 2009 Jan; 80(1):5. PubMed ID: 19212745
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diet therapy for cancer patients--"in the beginning for few, in the end for many"].
    Weimann A
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):663-5. PubMed ID: 16416364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Highlights in pulmonary hypertension].
    Olschewski H
    Pneumologie; 2007 Oct; 61(10):659-62. PubMed ID: 17659493
    [No Abstract]   [Full Text] [Related]  

  • 13. [New study results for internists].
    Stiefelhagen P
    Internist (Berl); 2010 Jan; 51(1):107-11. PubMed ID: 20104650
    [No Abstract]   [Full Text] [Related]  

  • 14. [The future and antimicrobial resistance].
    Huovinen P
    Duodecim; 1996; 112(11):946, 949. PubMed ID: 10592986
    [No Abstract]   [Full Text] [Related]  

  • 15. Who cares to pass this report card?
    Rockower S
    Md Med; 2007; 8(4):12-3. PubMed ID: 18773566
    [No Abstract]   [Full Text] [Related]  

  • 16. Improper use of tumour markers as cancer screening tests among Greek physicians.
    Ntaios G; Hatzitolios A; Savopoulos C
    Eur J Intern Med; 2009 Sep; 20(5):e128. PubMed ID: 19712837
    [No Abstract]   [Full Text] [Related]  

  • 17. Chips to bedside: incorporation of microarray data into clinical practice.
    Pusztai L
    Clin Cancer Res; 2006 Dec; 12(24):7209-14. PubMed ID: 17189391
    [No Abstract]   [Full Text] [Related]  

  • 18. [High follow-up, low follow-up, no follow-up?].
    Voit C
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):869-70. PubMed ID: 17910668
    [No Abstract]   [Full Text] [Related]  

  • 19. The difficult trials.
    Herrstedt J
    Onkologie; 2009 Feb; 32(1-2):7-8. PubMed ID: 19209012
    [No Abstract]   [Full Text] [Related]  

  • 20. The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
    Weissert R
    Expert Rev Neurother; 2006 Nov; 6(11):1587-90. PubMed ID: 17144774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.